Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
JAN STERN REED Insider Profile
4 Followers
JAN STERN REED, Director at Stepan Company, holds 87.36K shares in AngioDynamics (Ticker: ANGO), holds 40.99K shares in Avita Medical (Ticker: RCEL), holds 11.41K shares in Stepan Company (Ticker: SCL).
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+29.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that JAN STERN REED holds in companies
Most Profitable Insider Trade
The most profitable trade made by JAN STERN REED
JAN STERN REED's Trading History
Stepan Company
May 14, 2024
Director
Uninformative Buy
124.98K
$887.78K
AngioDynamics
Jul 19, 2024
Director
Uninformative Buy
―
$610.64K
Avita Medical
Jun 06, 2024
Director
Uninformative Buy
―
$535.73K
List of latest transactions for each holding click on a transaction to see JAN STERN REED's performance on stock
You May Also Like
JAN STERN REED insider profile FAQ
What is the percentage of profitable transactions made by JAN STERN REED?
The percentage of profitable transactions made by JAN STERN REED is 100%.
What is the average return per transaction made by JAN STERN REED?
The average return per transaction made by JAN STERN REED is 29.30%.
What stocks does JAN STERN REED hold?
JAN STERN REED holds: SCL, ANGO, RCEL stocks.
What was JAN STERN REED’s latest transaction?
JAN STERN REED latest transaction was an Uninformative Buy of ―.
What was JAN STERN REED's most profitable transaction?
JAN STERN REED’s most profitable transaction was an Informative Buy of SCL stock on October 29, 2015. The return on the trade was 33.20%.
What is JAN STERN REED's role in Stepan Company?
JAN STERN REED's role in Stepan Company is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.